Kintara Therapeutics Inc. buy melinda
Start price
13.10.21
/
50%
€0.99
Target price
13.10.22
€1.50
Performance (%)
-23.86%
End price
24.10.21
€0.75
Summary
This prediction ended on 24.10.21 with a price of €0.75. The price of Kintara Therapeutics Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -23.86%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Kintara Therapeutics Inc. | - | - | - |
iShares Core DAX® | -1.670% | -1.001% | 10.864% |
iShares Nasdaq 100 | -4.184% | -1.145% | 37.458% |
iShares Nikkei 225® | -4.967% | -5.783% | 18.828% |
iShares S&P 500 | -2.834% | -0.572% | 25.875% |
According to melinda what are the pros and cons of Kintara Therapeutics Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Delmar Pharmaceuticals Inc. diskutieren
Buy mit Kursziel 1,5
In the thread Trading Delmar Pharmaceuticals Inc.
Buy beendet
Stopped prediction by melinda for Kintara Therapeutics Inc.
Kintara Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.081
09.04.23
09.04.23
€0.15
-
02.05.23
02.05.23
Could be worthwhile Investment >10% per year
Kintara Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.21
29.09.20
29.09.20
€1.80
04.11.21
04.11.21
-18.78%
13.10.21
13.10.21
Could be worthwhile Investment >10% per year